Inhibitors of Cyclin-Dependent Kinases as Anti-Cancer Therapeutics
Keywords: ATP antagonist; Anti cancer Theraputics; Anti kainase activity; Anti tumor activity; Binectariferum; CDK Inhibitory and apoptosis; CDK Inhibitory properties; Cyclin Dependent Kinases; Cytotoxic; Flavonoids; Hydroxyellipticine; INK4 CKIs; Indigoids; KIP CIP CKIs; Mammalian CDKs and Cyclins; Non specific CDK inhibitors; Peptide Liabrary Approaches; Rohitukine analogeues; Staurosporine; paullones
Document Type: Review Article
Publication date: 2000-12-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.